| Catalog Number |
20039E |
| Medical Device Problem Code |
Complete Blockage (1094)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
09/13/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
E.1.Initial reporter facility name: (b)(6) hospital.H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
|
| |
|
Event or Problem Description
|
|
It was reported that the bd alaris smartsite extension set was occluded.The following information was provided by the initial reporter: unable to bolus.
|
| |
|
Event or Problem Description
|
|
No further information.
|
| |
|
Additional Manufacturer Narrative
|
|
Investigation result: one 20039e sample was received without packaging for investigation.No residual fluid was present in the sample and no connecting product was available to aid the investigation.The customer reported "unable to bolus".The returned sample was subjected to functional testing by priming using a 50ml bd plastipak syringe; the smartsite remained occluded after several attempts of connection and disconnection.When connected to a syringe, the smartsite piston remained closed.The details of this feedback were forwarded to the manufacturing site for investigation.Following a small number of similar reports, bd has conducted an in-depth investigation to identify any potential contributing factors for occlusion at the smartsite of this nature.The investigation has determined that a potential contributor could be the result of an insufficient amount of fluorosilicone having been injected into the piston of the smartsite during the assembly process; fluorosilicone is used as a lubricant within the smartsite to ensure the consistent opening of the piston when the smartsite is activated, and an insufficient amount may cause a temporary occlusion.They confirmed that the incorrect amount of fluorosilicone was likely due to a fault within the assembly machine during manufacture of the affected smartsite.A lot number was not provided as part of the investigation; however a review of the laser id from the smartsite component confirmed a possible lot number to be either lot 25055365 or 25055366.A review of the production records for lots 25055365 or 25055366 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.Since the manufacture of the reported lot, the automatic assembly machine has been repaired to ensure the fluorosilicone is being correctly dispensed into each smartsite; furthermore at the start of the assembly process the manufacturing operative will continue to measure whether a sufficient amount of fluorosilicone is being injected.The quality team at the manufacturing site has been informed of this report and will continue to monitor the incoming feedback and remain vigilant to issues of this nature during future production.A review of the customer feedback database indicates that reports of this nature against products in the smartsite product family are rare and have been occurring at a low frequency within the last 12 months.
|
| |
|
Search Alerts/Recalls
|